Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Colon cancer (CC) pathological staging fails to accurately predict recurrence, and to date, no gene expression signature has proven reliable for prognosis stratification in clinical practice, perhaps because CC is a heterogeneous disease. The aim of this study was to establish a comprehensive molecular classification of CC based on mRNA expression profile analyses. METHODS AND FINDINGS: Fresh-frozen primary tumor samples from a large multicenter cohort of 750 patients with stage I to IV CC who underwent surgery between 1987 and 2007 in seven centers were characterized for common DNA alterations, including BRAF, KRAS, and TP53 mutations, CpG island methylator phenotype, mismatch repair status, and chromosomal instability status, and were screened with whole genome and transcriptome arrays. 566 samples fulfilled RNA quality requirements. Unsupervised consensus hierarchical clustering applied to gene expression data from a discovery subset of 443 CC samples identified six molecular subtypes. These subtypes were associated with distinct clinicopathological characteristics, molecular alterations, specific enrichments of supervised gene expression signatures (stem cell phenotype-like, normal-like, serrated CC phenotype-like), and deregulated signaling pathways. Based on their main biological characteristics, we distinguished a deficient mismatch repair subtype, a KRAS mutant subtype, a cancer stem cell subtype, and three chromosomal instability subtypes, including one associated with down-regulated immune pathways, one with up-regulation of the Wnt pathway, and one displaying a normal-like gene expression profile. The classification was validated in the remaining 123 samples plus an independent set of 1,058 CC samples, including eight public datasets. Furthermore, prognosis was analyzed in the subset of stage II-III CC samples. The subtypes C4 and C6, but not the subtypes C1, C2, C3, and C5, were independently associated with shorter relapse-free survival, even after adjusting for age, sex, stage, and the emerging prognostic classifier Oncotype DX Colon Cancer Assay recurrence score (hazard ratio 1.5, 95% CI 1.1-2.1, p = 0.0097). However, a limitation of this study is that information on tumor grade and number of nodes examined was not available. CONCLUSIONS: We describe the first, to our knowledge, robust transcriptome-based classification of CC that improves the current disease stratification based on clinicopathological variables and common DNA markers. The biological relevance of these subtypes is illustrated by significant differences in prognosis. This analysis provides possibilities for improving prognostic models and therapeutic strategies. In conclusion, we report a new classification of CC into six molecular subtypes that arise through distinct biological pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Summary of the main characteristics of the six subtypes. Symbols correspond to the relative frequency within the subtype (o: very low frequencies [∼0%]; +++: very high frequencies; +/++: intermediate frequencies), and arrows indicate significant enrichment of subtype up- and down-regulated genes in most of the pathways of the given category. EMT, epithelial–mesenchymal transition; SC, stem cell; Wnt pw, Wnt pathway.](https://figures.cochat.ai/paper-figures/d9e6ea3312ee4d83b17b55c403c90fdb/gene-expression-classification-of-colon-cancer-into-molecular-subtypes-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [23]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Similar results were seen in Marisa 458 CMS1-4 CRC tumors (Fig. 8d).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Summaries of Affymetrix GeneChip probe level data
Irizarry, R. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gng015 · Cited by 4,887
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Greenlee, R. T., Murray, T., Bolden, S., & Wingo, P. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.1.7 · Cited by 3,850
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116 · cited 1×
“To obtain a robust classification, we used a consensus unsupervised approach [22] implemented in the R package ConsensusClusterPlus.”
MethodWeisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
Research works printed but not linked: 1
- American Joint Committee on Cancer (1997) AJCC cancer staging manual, 5th edition. Philadelphia: Lippincott-Raven.
Cited by
Items 601–700 of 1,001
GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer
Lisby, A., Flickinger, J. C., Bashir, B., Weindorfer, M., Shelukar, S., Crutcher, M. M., Snook, A. E., & Waldman, S. A. (2021) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2021.1876518 · Cited by 21
Romain, B., Benbrika, R., Marisa, L., Legrain, M., Lobstein, V., Oravecz, A., Poidevin, L., Bour, C., Freund, J., Duluc, I., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16323 · Cited by 21
Self-citationBlocker, S. J., Douglas, K. A., Polin, L., Lee, H., Hendriks, B. S., Lalo, E., Chen, W., & Shields, A. F. (2017) · Theranostics · doi:10.7150/thno.21688 · Cited by 21
Smeby, J., Sveen, A., Bergsland, C. H., Eilertsen, I. A., Danielsen, S. A., Eide, P. W., Hektoen, M., Guren, M. G., Nesbakken, A., Bruun, J., et al. (2019) · ESMO Open · doi:10.1136/esmoopen-2019-000523 · Cited by 21
EGFR controls transcriptional and metabolic rewiring in KRASG12D colorectal cancer
Krauß, D., Moreno‐Viedma, V., Adachi-Fernandez, E., Fernandes, C. D. S., Genger, J., Fari, O., Blauensteiner, B., Kirchhofer, D., Bradaric, N., Gushchina, V., et al. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00240-4 · Cited by 20
Pan-organ transcriptome variation across 21 cancer types
Hu, W., Yang, Y., Li, X., & Zheng, S. S. (2016) · Oncotarget · doi:10.18632/oncotarget.14303 · Cited by 20
Bergquist, J. R., Murphy, B. L., Storlie, C. B., Habermann, E. B., & Boughey, J. C. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6010-4 · Cited by 20
Establishment of an immune-related gene pair model to predict colon adenocarcinoma prognosis
Luo, J., Liu, P., Wang, L., Huang, Y., Wang, Y., Geng, W., Chen, D., Bai, Y., & Yang, Z. (2020) · BMC Cancer · doi:10.1186/s12885-020-07532-7 · Cited by 20
Astarita, J. L., Keerthivasan, S., Husain, B., Şenbabaoğlu, Y., Verschueren, E., Gierke, S., Pham, V. C., Peterson, S. M., Chalouni, C. M., Pierce, A. A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260800 · Cited by 20
Construction and Verification of a Fibroblast-Related Prognostic Signature Model for Colon Cancer
Zhao, Z., Li, W., Zhu, L., Xu, B., Jiang, Y., Ma, N., Liu, L., Qiu, J., & Zhang, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.908957 · Cited by 20
SELENBP1 Inhibits Cell Proliferation and Migration in Colorectal Cancers by Suppressing EMT
Zhang, X., Hong, R., Bei, L., Hu, Z., Yang, X., Song, T., Chen, L., Meng, H., Niu, G., & Ke, C. (2021) · Open Medicine · doi:10.1515/med-2022-0532 · Cited by 20
A 65‑gene signature for prognostic prediction in colon adenocarcinoma
Jiang, H., Du, J., Gu, J., Jin, L., Pu, Y., & Fei, B. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3401 · Cited by 20
Comprehensive identification of long noncoding RNAs in colorectal cancer
de Bony, E. J., Bizet, M., Grembergen, O. V., Hassabi, B., Calonne, E., Putmans, P., Bontempi, G., & Fuks, F. (2018) · Oncotarget · doi:10.18632/oncotarget.25218 · Cited by 20
Strowitzki, M. J., Radhakrishnan, P., Pavicevic, S., Scheer, J., Kimmer, G., Ritter, A. S., Tuffs, C., Volz, C., Vondran, F. W. R., Harnoss, J. M., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0406-9 · Cited by 20
Genome-wide analysis identifies critical DNA methylations within NTRKs genes in colorectal cancer
Chen, Z., Huang, Z., Luo, Y., Zou, Q., Bai, L., Tang, G., Wang, X., Cao, G., Huang, M., Xiang, J., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02740-6 · Cited by 20
Chromosome 20q11.21 Amplifications in Colorectal Cancer
Voutsadakis, I. A. (2021) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20274 · Cited by 20
Liang, Q., Wu, J., Zhao, X. S., Shen, S., Zhu, C., Liu, T., Cui, X., Chen, L., Wei, C., Cheng, P., et al. (2021) · Theranostics · doi:10.7150/thno.63202 · Cited by 20
Ayton, S. G., Pavlicová, M., Robles‐Espinoza, C. D., Tamez‐Peña, J. G., & Treviño, V. (2021) · Genetics in Medicine · doi:10.1016/j.gim.2021.09.006 · Cited by 20
Ong, C. W., Chong, P. Y., McArt, D. G., Chan, J. Y., Tan, H. T., Kumar, A. P., Chung, M. C. M., Clement, M., Soong, R., Schaeybroeck, S. V., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3497 · Cited by 20
Panitumumab safety for treating colorectal cancer
Stremitzer, S., Sebio, A., Stintzing, S., & Lenz, H. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.915024 · Cited by 20
Borelli, B., Fontana, E., Giordano, M., Antoniotti, C., Lonardi, S., Bergamo, F., Pietrantonio, F., Morano, F., Tamburini, E., Boccaccino, A., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100073 · Cited by 21
Cheng, Z., Min, L., Liu, J., Tian, W., Han, Y. K., Qu, L., & Shou, C. (2016) · Tumor Biology · doi:10.1007/s13277-016-5454-7 · Cited by 20
Wang, Z., Song, J., Azami, N. L. B., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.802665 · Cited by 19
Sriramulu, S., Malayaperumal, S., Banerjee, A., Anbalagan, M., Kumar, M. M., Radha, R. K. N., Liu, X., Zhang, H., Hu, G., Sun, X., et al. (2024) · Current Gene Therapy · doi:10.2174/0115665232273077240104045022 · Cited by 19
Lei, J.-X., Wang, R., Hu, C., Lou, X., Lv, M., Li, C., Gai, B., Wu, X., Dou, R., Cai, D., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001684 · Cited by 19
Transcriptomic subtyping of gastrointestinal malignancies
de Back, T. R., van Hooff, S. R., Sommeijer, D. W., & Vermeulen, L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.06.007 · Cited by 19
Lee, H. J., Kwak, Y., Na, Y. S., Kim, H.-J., Park, M. R., Jo, J. Y., Kim, J. Y., Cho, S., & Kim, P. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100843 · Cited by 19
Li, J., Xue, W., Lv, J., Han, P., Liu, Y., & Cui, B. (2017) · Oncotarget · doi:10.18632/oncotarget.17924 · Cited by 19
Mutational Mechanisms That Activate Wnt Signaling and Predict Outcomes in Colorectal Cancer Patients
Hankey, W., McIlhatton, M. A., Ebede, K., Kennedy, B., Hancioglu, B., Zhang, J., Brock, G. N., Huang, K., & Groden, J. L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1357 · Cited by 19
Immune landscape and biomarkers for immuno-oncology in colorectal cancers
Bae, J. M., Yoo, S.-Y., Kim, J. H., & Kang, G. H. (2020) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2020.05.15 · Cited by 19
Liu, X., Yan, G., Xu, B., Yu, H., An, Y., & Sun, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006501 · Cited by 19
Shelygin, Y. A., Поспехова, Н. И., Шубин, В. П., Кашников, В. Н., Frolov, S. A., Sushkov, O. I., Иванович, А. С., & Цуканов, А. С. (2014) · BioMed Research International · doi:10.1155/2014/629496 · Cited by 19
Corry, S. M., McCorry, A. M., Lannagan, T. R., Leonard, N. A., Fisher, N. C., Byrne, R. M., Tsantoulis, P., Cortes-Lavaud, X., Amirkhah, R., Redmond, K. L., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326183 · Cited by 18
An integral genomic signature approach for tailored cancer therapy using genome-wide sequencing data
Wang, X., Lee, S., Zhang, H., Tang, G., & Wang, Y. (2022) · Nature Communications · doi:10.1038/s41467-022-30449-7 · Cited by 18
Guo, Y., Yuan, C., Huang, T., & Cheng, Z. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118576 · Cited by 18
Qin, Y., Wang, Q., Lin, Q., Liu, F., Pan, X., Wei, C., Chen, J., Huang, T., Fang, M., Yang, W., et al. (2025) · mSystems · doi:10.1128/msystems.00805-24 · Cited by 18
Colorectal Cancer Prognosis Is Not Associated with BRAF and KRAS Mutations-A STROBE Compliant Study
Lee, J., Ahn, J., Park, W. S., Choe, E. K., Kim, E. Y., Shin, R., Heo, S., Jung, S., Kim, K., Chai, Y. J., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010111 · Cited by 18
High MICB expression as a biomarker for good prognosis of colorectal cancer
Feng, Q., Yu, S., Mao, Y., Ji, M., Wei, Y., He, G., Chang, W., Zhu, D., Ren, L., & Xu, J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03159-0 · Cited by 18
Khawaja, H. A., Campbell, A. D., Roberts, J. Z., Javadi, A., O’Reilly, P. G., McArt, D. G., Allen, W. L., Majkut, J., Rehm, M., Bardelli, A., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03131-3 · Cited by 19
Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
Li, M., Yuan, J., Guan, X., Ma, N., & Liu, M. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00246-x · Cited by 18
Uchuya-Castillo, J., Aznar, N., Frau, C., Martinez, P., Nevé, C. L., Marisa, L., Penalva, L. O. F., Laurent‐Puig, P., Puisieux, A., Scoazec, J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25741 · Cited by 18
Self-citationLong term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report
Callebout, E., Ribeiro, S. M., Laurent, S., Man, M. D., Ferdinande, L., Claes, K., der Meulen, J. V., & Geboes, K. (2019) · BMC Cancer · doi:10.1186/s12885-019-5763-5 · Cited by 18
Dietinger, V., de Durango, C. G., Wiechmann, S., Boos, S. L., Michl, M., Neumann, J. H. L., Hermeking, H., Küster, B., & Jung, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00561-6 · Cited by 18
Nasca, V., Zhao, J. J., Ros, J., Lonardi, S., Zwart, K., Cohen, R., Fakih, M., Jayachandran, P., Roodhart, J. M. L., Derksen, J. W. G., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010598 · Cited by 17
Self-citationHigh KCNQ1OT1 Expression Might Independently Predict Shorter Survival of Colon Adenocarcinoma
Zhang, K., Yan, J., Yi, B., Rui, Y., & Hu, H. (2019) · Future Oncology · doi:10.2217/fon-2018-0499 · Cited by 17
Cao, S., Chen, C., Gu, D., Wang, Z., & Xu, G. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.991881 · Cited by 17
Gu, C., Tang, L., Hao, Y., Dong, S., Shen, J., Xie, F., Han, Z., Luo, W., He, J., & Li, Y. (2023) · Journal of Cancer · doi:10.7150/jca.85517 · Cited by 17
Zhang, D., Sun, R., Di, C., Li, L., Zhao, F., Han, Y., & Zhang, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107406 · Cited by 17
Xun, D., Li, X., Huang, L. J., Zhao, Y., Chen, J., & Qi, X. (2024) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-24-325 · Cited by 17
Wei, F., Xu, X., Wang, J., Mei, S. W., Zhao, F. Q., Huang, F., Xiao, T., Wang, G., Wei, B., Huang, S., et al. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-024-03887-z · Cited by 17
Qin, J., Hu, S., Chen, Y., Xu, M., Xiao, Q., Lou, J., Ding, M., Sun, H., Xu, T., Pan, Y., et al. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.23882 · Cited by 17
Identification of Key Genes in Colorectal Cancer Regulated by miR-34a
Wang, T., Xu, H., Liu, X., Chen, S., Zhou, Y., & Zhang, X. (2017) · Medical Science Monitor · doi:10.12659/msm.904937 · Cited by 17
Shi, M., Wang, J., & Zhang, C. (2019) · Molecular Informatics · doi:10.1002/minf.201900028 · Cited by 17
Ciardiello, D., Blauensteiner, B., Matrone, N., Belli, V., Mohr, T. T., Vitiello, P. P., Martini, G., Poliero, L., Cardone, C., Napolitano, S., et al. (2021) · Medical Oncology · doi:10.1007/s12032-021-01464-3 · Cited by 17
Electronic Imaging to Enhance Lesion Detection at Colonoscopy
Ket, S., Bird-Lieberman, E. L., & East, J. E. (2015) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2014.11.011 · Cited by 17
Shi, M., & He, J. (2016) · PeerJ · doi:10.7717/peerj.1804 · Cited by 17
Cao, B., Luo, L., Feng, L., Ma, S., Chen, T., Ren, Y., Zha, X., Cheng, S., Zhang, K., & Chen, C. (2017) · BMC Cancer · doi:10.1186/s12885-017-3821-4 · Cited by 17
Stage-Dependent Gene Expression Profiling in Colorectal Cancer
Kim, M.-S., Kim, D., & Kim, J. (2018) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2814043 · Cited by 17
Liu, Q., Deng, J., Wei, X., Yuan, W., & Ma, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28403 · Cited by 17
Chu, Y., Liu, Z., Liu, J., Yu, L., Zhang, D., & Pei, F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00503 · Cited by 17
Wang, S., Liu, Y., Shi, Y. Y., Guan, J., Liu, M., & Wang, W. (2021) · Journal of International Medical Research · doi:10.1177/03000605211015023 · Cited by 17
Wielandt, A. M., Villarroel, C., Hurtado, C., Simian, D., Zamorano, D., Martínez, M., Castro, M., Vial, M. T., Kronberg, U., & López-Köstner, F. (2017) · Revista médica de Chile · doi:10.4067/s0034-98872017000400001 · Cited by 17
Song, K., Zhao, W., Wang, W., Zhang, N., Wang, K., & Chang, Z. (2018) · Cancer Science · doi:10.1111/cas.13622 · Cited by 17
A Novel Discriminating Colorectal Cancer Model for Differentiating Normal and Tumor Tissues
Sun, X., Tian, Y., Zheng, Q., Zheng, R., Lin, A., Chen, T., Zhu, Y., & Lai, M. (2018) · Epigenomics · doi:10.2217/epi-2018-0063 · Cited by 16
Xu, C., Xia, P., Li, J., Lewis, K. B., Ciombor, K. K., Wang, L., Smith, J. J., Beauchamp, R. D., & Chen, X. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101661 · Cited by 16
Sun, T.-Y., Chen, Y., & Chen, Y.-X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575829 · Cited by 16
Strbenac, D., Mann, G. J., Yang, J. Y. H., & Ormerod, J. T. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw444 · Cited by 16
Newell, E. W., & Becht, É. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0519 · Cited by 16
Guo, X., Tang, Y., & Zhu, W. (2018) · BMC Genomics · doi:10.1186/s12864-018-5165-0 · Cited by 16
Huang, M. S., & Wang, Y. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00938 · Cited by 16
Caiazza, F., Oficjalska, K., Tosetto, M., Phelan, J. J., Noonan, S. A., Martin, P., Killick, K. E., Breen, L., O’Neill, F., Nolan, B., et al. (2019) · American Journal Of Pathology · doi:10.1016/j.ajpath.2019.07.004 · Cited by 16
Zhao, L., & Li, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.11643 · Cited by 16
Sibilio, A., Suñer, C., Fernández‐Alfara, M., Martín, J., Berenguer, A., Calon, A., Chanes, V., Millanes‐Romero, A., Fernández‐Miranda, G., Batlle, E., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103790 · Cited by 16
Kenneth, M. J., Shishir, T. A., & Haque, F. K. M. (2023) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-023-00532-7 · Cited by 16
Cao, Y., Wang, D., Wu, J., Yao, Z., Shen, S., Niu, C., Liu, Y., Zhang, P., Wang, Q., Wang, J., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad362 · Cited by 16
Wang, C., Zhou, Y., Ruan, R., Zheng, M., Han, W., & Liao, L. (2015) · Europe PMC (PubMed Central) · Cited by 17
Revannasiddaiah, S., Thakur, P., Bhardwaj, B., Susheela, S. P., & Madabhavi, I. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2014.05.19 · Cited by 17
Ringed Seal Search for Global Optimization via a Sensitive Search Model
Saadi, Y., Yanto, I. T. R., Herawan, T., Balakrishnan, V., Chiroma, H., & Risnumawan, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0144371 · Cited by 16
Larsson, A. H., Lehn, S., Wangefjord, S., Karnevi, E., Kuteeva, E., Sundström, M., Nodin, B., Uhlén, M., Eberhard, J., Birgisson, H., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0882-0 · Cited by 16
Hata, T., Takemasa, I., Takahashi, H., Haraguchi, N., Nishimura, J., Hata, T., Mizushima, T., Doki, Y., & Mori, M. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.163 · Cited by 16
Serine Threonine Kinase 17A Maintains the Epithelial State in Colorectal Cancer Cells
Short, S. P., Thompson, J. J., Bilotta, A. J., Chen, X., Revetta, F. L., Washington, M. K., & Williams, C. S. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0990 · Cited by 16
Wu, Y., Zhang, S., & Yan, J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11289 · Cited by 16
Prognostic implications of an autophagy-based signature in colorectal cancer
Wang, L., Jiang, X., Zhang, X., & Shu, P. (2021) · Medicine · doi:10.1097/md.0000000000025148 · Cited by 16
Cohen, R., Svrcek, M., Dreyer, C., Cervera, P., Duval, A., Pocard, M. D., Fléjou, J., de Gramont, A., & André, T. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0504-2 · Cited by 16
Self-citationImaging and clinical correlates with regorafenib in metastatic colorectal cancer
Khan, K. H., Cascinu, S., Cunningham, D., Kim, S., Oki, E., Seery, T. E., Shen, L., Siena, S., Tournigand, C., Turhal, N. S., et al. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102020 · Cited by 16
Li, W., Zhi, W., Zou, S., Qiu, T., Ling, Y., Shan, L., Shi, S., & Ying, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128202 · Cited by 16
Downregulation of B3GNT6 is a predictor of poor outcomes in patients with colorectal cancer
Xiao, S., Chen, Y., Zhang, Y., & Lai, C. (2022) · World Journal of Surgical Oncology · doi:10.1186/s12957-022-02561-x · Cited by 15
Yuan, S., Gao, Y., Xia, Y., Wang, Z., & Wang, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1008644 · Cited by 15
Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
Li, M., Song, J., Wang, L., Wang, Q., Huang, Q., & Mo, D. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1253169 · Cited by 15
Wu, J., Li, W., Su, J., Zheng, J., Liang, Y., Lin, J., Xu, B., & Liu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-62913-3 · Cited by 15
Sun, Y., Zhu, S.-X., Chen, X., Pan, Q., An, Y., Chen, T.-Q., Huang, H., Pu, K., Lian, J.-Y., Zhao, W., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.10.036 · Cited by 15
Robust Significance Analysis of Microarrays by Minimumβ-Divergence Method
Shahjaman, M., Kumar, N., Mollah, M. M. H., Ahmed, M. S., Begum, A. A., Islam, S. M. S., & Mollah, M. N. H. (2017) · BioMed Research International · doi:10.1155/2017/5310198 · Cited by 15
Novel insights into transcriptional dysregulation in colorectal cancer
Feodorova, Y. N., Tashkova, D., Koev, I. G., Todorov, A. T., Kostov, G., Simitchiev, K., Belovejdov, V., Dimov, R., & Sarafian, V. S. (2018) · Neoplasma · doi:10.4149/neo_2018_170707n467 · Cited by 15
High c-Myb Expression Associates with Good Prognosis in Colorectal Carcinoma
Tichý, M., Knopfová, L., Jarkovský, J., Vlček, P., Katolická, J., Čapov, I., Hermanová, M., Šmarda, J., & Beneš, P. (2019) · Journal of Cancer · doi:10.7150/jca.29530 · Cited by 15
Molecular classification of breast cancer using the mRNA expression profiles of immune-related genes
Mei, J., Zhao, J. J., & Fu, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-61710-y · Cited by 15
Galamb, O., Kalmár, A., Sebestyén, A. R., Dankó, T., Kriston, C., Fűri, I., Hollósi, P., Csabai, I., Wichmann, B., Krenács, T., et al. (2020) · Pathology & Oncology Research · doi:10.1007/s12253-020-00800-8 · Cited by 15
Chan, H.-C., Chattopadhyay, A. S., Chuang, E. Y.-Y., & Lu, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631056 · Cited by 15
Zhang, Z., Ji, M., Li, J., Wu, Q., Huang, Y., He, G., & Xu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.636591 · Cited by 15
Wang, R., Zhao, W., Yang, H., Dong, J.-M., Lin, W. V., He, F., Cui, M., & Zhou, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.765578 · Cited by 15
Wang, D., Dai, J., Suo, C., Wang, S., Zhang, Y., & Chen, X. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1033214 · Cited by 15
Metadata
- Authors
- Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., Kirzin, S., Chazal, M., Fléjou, J.-F., Benchimol, D., Berger, A., Lagarde, A., Pencreach, E., Piard, F., Elias, D., Parc, Y., Olschwang, S., Milano, G., Laurent-Puig, P., & Boige, V.
- Affiliations
- Inserm (FR)
- Hôpitaux Universitaires de Strasbourg (FR)
- La Ligue Contre le Cancer (FR)
- Université Toulouse III - Paul Sabatier (FR)
- Centre Hospitalier Universitaire de Nice (FR)
- Hôpital Européen Georges-Pompidou (FR)
- CHU Dijon Bourgogne (FR)
- Institut Gustave Roussy (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-21
- Volume
- 10
- Issue
- 5
- Pages
- e1001453
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC3660251
- OpenAlex
- W2154941270
- Cited by
- 1,507
- References
- 40
- Citations by year
- 2026: 84 · 2025: 111 · 2024: 108 · 2023: 142 · 2022: 145 · 2021: 194 · 2020: 131 · 2019: 126 · 2018: 131 · 2017: 108 · 2016: 90 · 2015: 74 · 2014: 53 · 2013: 8
- FWCI
- 56.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- American Association for Cancer Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- colon cancer, molecular subtypes, gene expression signatures, mismatch repair deficiency, chromosomal instability, KRAS mutation, BRAF mutation, TP53 mutation, CpG island methylator phenotype, Wnt signaling, relapse-free survival, prognosis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Colonic Neoplasms, Female, France, Genetic Testing, Humans, Lymphatic Metastasis, Male, Middle Aged, Neoplasm Staging, Phenotype, Predictive Value of Tests, Prognosis, Risk Factors, RNA, Messenger, Time Factors, Biomarkers, Tumor, Reproducibility of Results, Gene Expression Regulation, Neoplastic, Multivariate Analysis, Cluster Analysis, Chi-Square Distribution, Logistic Models, Proportional Hazards Models, Risk Assessment, Genetic Predisposition to Disease, Gene Expression Profiling, Kaplan-Meier Estimate, Young Adult, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.